Biotech Values

[mcbio]

ASMB hits 14-month low—perhaps related to ABUS sell-off today.

Yes, I'll admit this one has been a big disappointment since I took a position, but I'm still holding in full. I'm not aware of a real good reason for shares being down nearly 40% or so in the past 3 months. Not clear to me that any competitor's HBV data has weakened ASMB's prospects and not clear to me that ASMB itself has reported anything new that should warrant such a downturn. If shares are still around this level at year-end, I'll probably be forced to realize a tax loss and then would plan to buy back after thirty days.